Pfizer, Moderna COVID-19 Shots Work for Children Under 5, FDA Says
MONDAY, June 13, 2022 (HealthDay News) — Antibody levels suggest that three doses of the Pfizer pediatric COVID-19 vaccine help guard children younger than 5 years against infection, a new analysis from the U.S. Food and Drug Administration shows.The…
Learn MoreStrategies to Reduce IV Contrast Use for CT Scans Compared
MONDAY, June 13, 2022 (HealthDay News) — Intravenous contrast use for computed tomography (CT) scans could be reduced by about 80 percent using a combination of dose reduction strategies, according to a research letter published online June 9 in the …
Learn MoreAnother Study Finds Ivermectin Useless Against COVID-19
MONDAY, June 13, 2022 (HealthDay News) — Yet another study shows that ivermectin provides no benefits for COVID-19 patients, but researchers say they’ll continue to study a higher dose of the drug.Even though the drug used for parasitic infections i…
Learn MorePolysubstance Use Common in Adults Seeking Substance Use Treatment
MONDAY, June 13, 2022 (HealthDay News) — Past 30-day polysubstance use is reported by 32.6 percent of adults who seek substance use treatment in the United States, according to research published in the June 10 issue of the U.S. Centers for Disease …
Learn More20 Minutes of Vigorous Physical Activity Daily Advised for Teens
MONDAY, June 13, 2022 (HealthDay News) — Twenty minutes of daily vigorous physical activity (VPA) seems to be best for maximizing cardiorespiratory fitness (CRF) in adolescents, according to a study published online June 13 in Pediatrics.Noting that …
Learn MorePerfluoroalkyl, Polyfluoroalkyl Substances Linked to HTN
MONDAY, June 13, 2022 (HealthDay News) — Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are associated with incident hypertension among midlife multiracial and multiethnic women, according to a study published online June 13 in Hypertension.Nin…
Learn MoreAACR: Cancer Disparities Represent Ongoing Public Health Challenge
MONDAY, June 13, 2022 (HealthDay News) — Racial and ethnic minorities and other medically underserved populations have a disproportionate share of the burden for certain types of cancer, according to a report issued by the American Association for Ca…
Learn MoreNew ALS Drug Approved in Canada While Still Under FDA Review
MONDAY, June 13, 2022 (HealthDay News) — An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effec…
Learn MoreHerpes Zoster Not Linked to Increased Dementia Risk
MONDAY, June 13, 2022 (HealthDay News) — Herpes zoster is not associated with increased dementia risk and may be associated with a small decrease in risk, according to a study published online June 8 in Neurology.Sigrun Alba Johannesdottir Schmidt, M…
Learn MoreDurability of mRNA-1273 Protection Against Symptomatic COVID-19 Examined
MONDAY, June 13, 2022 (HealthDay News) — For individuals who receive two doses of mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, vaccine efficacy (VE) against symptomatic COVID-19 appears to peak at 120 days after the…
Learn More